Evidence map›Paper›PMID 25887923›Full record

ReviewCritical care (London, England)2015

Renal replacement therapy in acute kidney injury: controversy and consensus.

Claudio Ronco, Zaccaria Ricci, Daniel De Backer, John A Kellum, Fabio S Taccone, Michael Joannidis, Peter Pickkers, Vincenzo Cantaluppi, Franco Turani, Patrick Saudan and 6 more

Registry-linked trialAbstract readReview
In one paragraph

Review in Critical care (London, England), 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05941624 (Comparison Between HA330 Hemoperfusion Filter Hemodialysis and Conventional High-Flux Filter Hemodialysis in Reducing Inflammatory Mediators in Renal Dysfunction Due to Sepsis), which is not on this map. Cited by 67 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
67citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05941624 nacompletednot on this mapstarted 2023, after this paper: background citation

Comparison Between HA330 Hemoperfusion Filter Hemodialysis and Conventional High-Flux Filter Hemodialysis in Reducing Inflammatory Mediators in Renal Dysfunction Due to Sepsis

TypeinterventionalSponsorIndonesia UniversityRan2023 to 2024Enrolled33ConditionsRenal Dysfunction, Sepsis, HemodialysisArmsHa-330 Hemoperfusion Filter Hemodialysis, Conventional Hemodialysis
3 · Its place in the literature

Who cites it

67 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Trial
  3. Trial
  4. Article
  5. Article
  6. Observational
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Prognostic death factors in secondary hemophagocytic lymphohistiocytosis children with multiple organ dysfunction syndrome receiving continuous renal replacement therapy: A multicenter prospective nested case-control study.Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy · 2022
    Article
  20. Article

7 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Claudio RoncoDepartment Nephrology Dialysis & Transplantation, International Renal Research Institute (IRRIV), San Bortolo Hospital, Viale Rodolfi, 36100, Vicenza, Italy. cronco@goldnet.it.
Zaccaria RicciDepartment of Cardiology and Cardiac Surgery, Pediatric Cardiac Intensive Care Unit, Bambino Gesù Children's Hospital, IRCCS, Piazza S. Onofrio 4, 00165, Rome, Italy. zaccaria.ricci@gmail.com.
Daniel De BackerDepartment of Intensive Care, Erasme Hospital, Université libre de Bruxelles, Route de Lennik 808, 1070, Brussels, Belgium. ddebacke@ulb.ac.be.
John A KellumCenter for Critical Care Nephrology, Department of Critical Care Medicine, University of Pittsburgh, 3550 Terrace Street, Pittsburgh, PA, 15261, USA. kellumja@ccm.upmc.edu.
Fabio S TacconeDepartment of Intensive Care, Erasme Hospital, Université libre de Bruxelles, Route de Lennik 808, 1070, Brussels, Belgium. ftaccone@ulb.ac.be.
Michael JoannidisDivision of Emergency and Intensive Care Medicine, Department of Internal Medicine, Medical University of Innsbruck, Anichstraße 35, 6020, Innsbruck, Austria. michael.joannidis@i-med.ac.at.
Peter PickkersDepartment of Intensive Care Medicine, Radboud University Medical Centre, PO Box 9101, 6500, HB, Nijmegen, The Netherlands. Peter.Pickkers@radboudumc.nl.
Vincenzo CantaluppiNephrology, Dialysis and Kidney Transplantation Unit, University of Torino, Azienda Ospedaliera Universitaria 'Città della Salute e della Scienza di Torino Presidio Molinette', Corso Bramante 88, 10126, Turin, Italy. vincenzo.cantaluppi@unito.it.
Franco TuraniDepartment of Intensive Care, Aurelia Hospital and European Hospital, Via Portuense 694, 00416, Rome, Italy. franco.turani@fastwebnet.it.
Patrick SaudanService of Nephrology, Department of Internal Medicine Specialties, University Hospital of Geneva, 4 rue Gabrielle Perret-Gentil, CH 1211, Geneva, Switzerland. Patrick.Saudan@hcuge.ch.
Rinaldo BellomoDepartment of Intensive Care, Austin Hospital, 145 Studley Road, Heidelberg, Melbourne, VIC, 3084, Australia. Rinaldo.BELLOMO@austin.org.au.
Olivier Joannes-BoyauCentre Hospitalier Universitaire (CHU) de Bordeaux, Service d'Anesthésie-Réanimation 2, Avenue de Magellan, F-33600, Pessac, France. olivier.joannes-boyau@chu-bordeaux.fr.
Massimo AntonelliUniversità Cattolica del Sacro Cuore - Policlinico Universitario A. Gemelli, Largo Agostino Gemelli 8, 00168, Rome, Italy. m.antonelli@rm.unicatt.it.
Didier PayenDepartment of Anesthesiology and Critical Care, Lariboisière Hospital, Assistance Publique-Hôpitaux de Paris, University of Paris, 7 Denis Diderot, 75475, Paris, Cedex 10, France. dpayen1234@orange.fr.
John R ProwleAdult Critical Care Unit, The Royal London Hospital, Barts Health, Whitechapel Road, London, E1 1BB, UK. john.prowle@bartshealth.nhs.uk.
Jean-Louis VincentDepartment of Intensive Care, Erasme Hospital, Université libre de Bruxelles, Route de Lennik 808, 1070, Brussels, Belgium. jlvincen@ulb.ac.be.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Renal replacement therapies (RRTs) represent a cornerstone in the management of severe acute kidney injury. This area of intensive care and nephrology has undergone significant improvement and evolution in recent years. Continuous RRTs have been a major focus of new technological and treatment strategies. RRT is being used increasingly in the intensive care unit, not only for renal indications but also for other organ-supportive strategies. Several aspects related to RRT are now well established, but others remain controversial. In this review, we review the available RRT modalities, covering technical and clinical aspects. We discuss several controversial issues, provide some practical recommendations, and where possible suggest a research agenda for the future.

Indexed as

Acute Kidney InjuryConsensusCritical IllnessHumansIntensive Care UnitsRenal Replacement Therapy

Identifiers

PMID25887923
PMCPMC4386097

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.